Back to Journals » Journal of Hepatocellular Carcinoma » The Emerging Multiple Modality Treatment Based on Systemic Therapy for Hepatocellular Carcinoma (HCC)

Journal of Hepatocellular Carcinoma

ISSN: 2253-5969


Journal Articles:

The Emerging Multiple Modality Treatment Based on Systemic Therapy for Hepatocellular Carcinoma (HCC)

Thanks to the rapid development of systemic therapy for HCC in the past 4 years, multi-modality treatments of systemic therapy combined with such aspects as surgery, TACE, transplantation, as well as related prognostic biomarkers, have become current hotspots. This Article Collection collects valuable evidence with various perspectives to provide reference for questions frequently discussed in the clinical practice of HCC treatment.

Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy

Li W, Zheng Z, Wang J, Wu T, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z

Journal of Hepatocellular Carcinoma 2024, 11:463-475

Published Date: 4 March 2024

Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma

Liu B, Gao S, Guo J, Kou F, Liu S, Zhang X, Feng A, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Xu L, Zhu X

Journal of Hepatocellular Carcinoma 2024, 11:477-488

Published Date: 4 March 2024

Effect of Different Liver Resection Modalities on the Prognosis of Patients with Hepatocellular Carcinoma on the Left Lateral Lobe

Liu J, Sun M, Fang K, Wang J, Ma B, Song L, Liu T, Tang M, Wang K, Xia Y

Journal of Hepatocellular Carcinoma 2023, 10:997-1007

Published Date: 28 June 2023

Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis

Ouyang J, Wang Z, Yuan K, Yang Y, Zhou Y, Li Q, Yang N, Zhao H, Zhao H, Zhou J

Journal of Hepatocellular Carcinoma 2023, 10:1465-1477

Published Date: 6 September 2023

The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors

Hsu HM, Tsai HI, Lee WC, Wang CC, Yu MC, Lin SM, Lin CY, Wu CH, Lee CW

Journal of Hepatocellular Carcinoma 2023, 10:1873-1880

Published Date: 24 October 2023

Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre

Li G, Zhao Y, Li K, Yang S, Xiang C, Song J, Yang Y, Li G, Dong J

Journal of Hepatocellular Carcinoma 2023, 10:2037-2048

Published Date: 9 November 2023

Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy

Zheng Z, Wang J, Wu T, He M, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z

Journal of Hepatocellular Carcinoma 2023, 10:2117-2132

Published Date: 30 November 2023

Predicting T Cell-Inflamed Gene Expression Profile in Hepatocellular Carcinoma Based on Dynamic Contrast-Enhanced Ultrasound Radiomics

Wang Y, Weng W, Liang R, Zhou Q, Hu H, Li M, Chen L, Chen S, Peng S, Kuang M, Xiao H, Wang W

Journal of Hepatocellular Carcinoma 2023, 10:2291-2303

Published Date: 18 December 2023

An Overview of Traditional Chinese Medicine in the Treatment After Radical Resection of Hepatocellular Carcinoma

Peng Y, Wu X, Zhang Y, Yin Y, Chen X, Zheng D, Wang J

Journal of Hepatocellular Carcinoma 2023, 10:2305-2321

Published Date: 18 December 2023